126 related articles for article (PubMed ID: 12946389)
41. 2,3,7,8-Tetrachlorodibenzo-p-dioxin equivalents in tissue samples from three species in the Denver, Colorado, USA, metropolitan area.
Coady KK; Jones PD; Giesy JP
Environ Toxicol Chem; 2001 Nov; 20(11):2433-42. PubMed ID: 11699766
[TBL] [Abstract][Full Text] [Related]
42. Toxic equivalency factors of polybrominated dibenzo-p-dioxin, dibenzofuran, biphenyl, and polyhalogenated diphenyl ether congeners based on rainbow trout early life stage mortality.
Hornung MW; Zabel EW; Peterson RE
Toxicol Appl Pharmacol; 1996 Oct; 140(2):227-34. PubMed ID: 8887438
[TBL] [Abstract][Full Text] [Related]
43. Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) disposition following pulmonary, oral, dermal, and parenteral exposures to rats.
Diliberto JJ; Jackson JA; Birnbaum LS
Toxicol Appl Pharmacol; 1996 May; 138(1):158-68. PubMed ID: 8658505
[TBL] [Abstract][Full Text] [Related]
44. Concentration of polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans and dioxin-like PCBs in human adipose tissue from Turkish men.
Cok I; Donmez MK; Hakan Satiroğlu M; Aydinuraz B; Henkelmann B; Kotalik J; Schramm KW
Chemosphere; 2007 Jan; 66(10):1955-61. PubMed ID: 16962637
[TBL] [Abstract][Full Text] [Related]
45. Interactions of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners for producing rainbow trout early life stage mortality.
Zabel EW; Walker MK; Hornung MW; Clayton MK; Peterson RE
Toxicol Appl Pharmacol; 1995 Oct; 134(2):204-13. PubMed ID: 7570596
[TBL] [Abstract][Full Text] [Related]
46. Transfer of polychlorinated dibenzo-p-dioxins and dibenzofurans to fetal and neonatal rats.
Van den Berg M; Heeremans C; Veenhoven E; Olie K
Fundam Appl Toxicol; 1987 Nov; 9(4):635-44. PubMed ID: 3692020
[TBL] [Abstract][Full Text] [Related]
47. Reproductive toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male rats: different effects of in utero versus lactational exposure.
Bjerke DL; Peterson RE
Toxicol Appl Pharmacol; 1994 Aug; 127(2):241-9. PubMed ID: 8048067
[TBL] [Abstract][Full Text] [Related]
48. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
49. A mechanistic model of effects of dioxin on thyroid hormones in the rat.
Kohn MC; Sewall CH; Lucier GW; Portier CJ
Toxicol Appl Pharmacol; 1996 Jan; 136(1):29-48. PubMed ID: 8560478
[TBL] [Abstract][Full Text] [Related]
50. Epidemiological problems with TCDD (a critical view).
Tognoni G; Bonaccorsi A
Drug Metab Rev; 1982; 13(3):447-69. PubMed ID: 7105971
[No Abstract] [Full Text] [Related]
51. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
52. A critical view of the mechanism(s) of toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Implications for human safety assessment.
Rozman K
Derm Beruf Umwelt; 1989; 37(3):81-92. PubMed ID: 2663408
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of potential transmission of 2,3,7,8-tetrachlorodibenzo-p-dioxin-contaminated incinerator emissions to humans via foods.
Fries GF; Paustenbach DJ
J Toxicol Environ Health; 1990; 29(1):1-43. PubMed ID: 2405173
[TBL] [Abstract][Full Text] [Related]
54. Physiologically based pharmacokinetic toolkit to evaluate environmental exposures: Applications of the dioxin model to study real life exposures.
Emond C; Ruiz P; Mumtaz M
Toxicol Appl Pharmacol; 2017 Jan; 315():70-79. PubMed ID: 27956220
[TBL] [Abstract][Full Text] [Related]
55. Dioxin exposure in breast milk and infant neurodevelopment in Vietnam.
Tai PT; Nishijo M; Anh NT; Maruzeni S; Nakagawa H; Van Luong H; Anh TH; Honda R; Kido T; Nishijo H
Occup Environ Med; 2013 Sep; 70(9):656-62. PubMed ID: 23390198
[TBL] [Abstract][Full Text] [Related]
56. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
[TBL] [Abstract][Full Text] [Related]
57. The early embryo loss caused by 2,3,7,8-tetrachlorodibenzo-p-dioxin may be related to the accumulation of this compound in the uterus.
Li B; Liu HY; Dai LJ; Lu JC; Yang ZM; Huang L
Reprod Toxicol; 2006 Apr; 21(3):301-6. PubMed ID: 16257174
[TBL] [Abstract][Full Text] [Related]
58. Determination of parameters responsible for pharmacokinetic behavior of TCDD in female Sprague-Dawley rats.
Wang X; Santostefano MJ; Evans MV; Richardson VM; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 1997 Nov; 147(1):151-68. PubMed ID: 9356318
[TBL] [Abstract][Full Text] [Related]
59. Repeated in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure affects male gonads in offspring, leading to sex ratio changes in F2 progeny.
Ikeda M; Tamura M; Yamashita J; Suzuki C; Tomita T
Toxicol Appl Pharmacol; 2005 Aug; 206(3):351-5. PubMed ID: 16039946
[TBL] [Abstract][Full Text] [Related]
60. Rapid distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) to embryonic tissues in C57BL/6N mice and correlation with palatal uptake in vitro.
Abbott BD; Birnbaum LS; Diliberto JJ
Toxicol Appl Pharmacol; 1996 Nov; 141(1):256-63. PubMed ID: 8917698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
